Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients — COVIDSOT  

Infections, Coronavirus Clinical Trial

Official title: Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients

Status Completed

Clinical Trial Summary

The overall purpose of this project is to better understand the incidence, risk factors, etiology, clinical manifestations and outcome of tCOVID19 in solid organ transplant recipients. The results obtained will allow us to gain insight on the need of antiviral treatment, on the strategy for complications surveillance, on how to adjust the immunosuppressant therapy and on the level of care in which each patient should be treated. In order to attain the objectives previously described we will develop a multicenter prospective study of consecutive cases of COVID-19 among solid organ transplant recipients.

Clinical Trial Description

There will be a clinical follow-up of the patients included in this study to observe possible complications and survival rate. Data collected form this study will be evaluated with a descriptive statistical analysis of the cohort consisting of analysis of the risk factors of COVID-19. Subsequently a multivaried logistic regression analysis will be performed in which the factors selected from the analysis and those clinically relevant. ;

Related Conditions & MeSH terms

• Coronavirus Infections
• COVID-19
• Infections, Coronavirus
• Transplant Recipient

• NCT number: NCT04319172
• Study type: Observational
• Source: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
• Status: Completed
• Start date: March 12, 2020
• Completion date: December 31, 2023